loading...

Patient’s Qualitative Assessment of Treatment version 2 (PQATv2)

Sanofi Aventis

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Published in 2019
  • Created from the PQATv1
Authors

Sanofi Aventis

Copyright
PQAT © Sanofi, 2016-2017
Objective
To provide early patient insights on benefits and disadvantages of drugs received within a clinical trial
Therapeutic area
  • Generic
Therapeutic indication

All

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK, USA & Canada
Bibliographic reference(s) of the original questionnaire

Adam Gater, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal and Aude Roborel de Climens. Tell me more: Exploring patient perspective on the benefits and disadvantages of drugs during clinical trials. #84209, DIA San Diego, USA, 2019 (Poster).

Adam Gater, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal and Aude Roborel de Climens. Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire to Explore Individualized Benefit-Harm of Drugs Received During Clinical Studies: an example in type 2 diabetes mellitus. (submitted to Drug Safety)

 

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Sanofi Aventis

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK, USA & Canada

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

PQATv2

English for the USA
German for Germany*
Hungarian for Hungary*
Polish for Poland*
Russian for Ukraine*
Spanish for the USA*
Ukrainian for Ukraine*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us